INBS 10-Q: SEC filing
Intelligent Bio Solutions Inc.
Filed with the SEC on · accession 0001493152-26-050881
INBS filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -2.0% by the first close after the filing.
Summary of the filing
Intelligent Bio Solutions Inc. filed its quarterly report on Form 10-Q for the fiscal quarter ended September 30, 2026, reporting routine financial results and disclosures.
Key details
How INBS stock reacted
Close before
$2.29
Nov 9, 2026
First close after
-1.97%
$2.25
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for INBS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for INBS?
Click hereFrequently asked questions
What did INBS file with the SEC on Nov 10, 2026?
INBS filed a 10-Q (SEC filing). Intelligent Bio Solutions Inc. filed its quarterly report on Form 10-Q for the fiscal quarter ended September 30, 2026, reporting routine financial results and disclosures.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did INBS stock react to this filing?
INBS closed at $2.29 before the filing and $2.25 on Nov 10, 2026 (-1.97%).
Other INBS SEC filings
- DEF 14A · SEC filingNov 2, 2026
- 10-K/A · RestatementOct 21, 2026
- 8-K · SEC filingOct 13, 2026
- EFFECT · SEC filingSep 23, 2026
- 424B3 · Secondary offeringSep 23, 2026
- S-3 · Shelf registrationSep 15, 2026
- 8-K · SEC filingSep 11, 2026
- 8-K · Fda approvalSep 9, 2026
- 8-K · Secondary offeringSep 2, 2026
- 8-K · Fda approvalSep 1, 2026
Get alerts when INBS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days